in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
AMRI to acquire API firm Cedarburg
10:18 AM MDT | March 24, 2014 | Deepti Ramesh
Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Hauser Pharmaceuticals (Grafton, WI), for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million. Cedarburg is a contract developer and manufacturer of technically complex active pharmaceutical ingredients (APIs) for both generic and branded customers. The transaction is expected to close in early April. Cedarburg's forecast for full-year 2014 revenue is about...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee